Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2023-11-02 00:00:00 ET · period of report 2023-10-31 · accession 0001209191-23-054163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-02 | 2023-10-31 | NTLA | Bhanji Muna | Dir | S - Sale | $23.90 | -265 | 12.0K | -2% | -$6,334 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-31 | S | D | 265 | $23.90 | 11,996 | D | — | — |